| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III ... At diagnosis, approximately 20–30 % of patients with non-small cell lung cancer (NSCLC) have stage III, locally advanced disease [1], of whom ...
| |||||
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment